Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2025-03-18 Sale |
2025-03-19 4:02 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
2,433 | $1.487 | $3,618 | 370,326 (Direct) |
View |
2025-02-19 Sale |
2025-02-20 4:50 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
239 | $1.868 | $446 | 159,759 (Direct) |
View |
2025-01-17 Sale |
2025-01-21 4:37 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
123 | $2.26 | $278 | 159,998 (Direct) |
View |
2024-12-17 Sale |
2024-12-18 4:13 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
2,234 | $2.429 | $5,426 | 160,121 (Direct) |
View |
2024-11-19 Sale |
2024-11-20 4:10 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
197 | $2.165 | $427 | 162,355 (Direct) |
View |
2024-10-17 Sale |
2024-10-18 4:08 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
107 | $2.119 | $227 | 162,552 (Direct) |
View |
2024-09-17 Sale |
2024-09-18 4:11 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
2,608 | $1.783 | $4,650 | 162,659 (Direct) |
View |
2024-08-19 Sale |
2024-08-20 4:03 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
211 | $1.946 | $411 | 165,267 (Direct) |
View |
2024-07-17 Sale |
2024-07-19 08:30 am |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
108 | $2.587 | $279 | 165,478 (Direct) |
View |
2024-06-18 Sale |
2024-06-20 4:16 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
2,540 | $2.856 | $7,254 | 165,586 (Direct) |
View |
2024-05-17 Sale |
2024-05-20 4:14 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
192 | $2.483 | $477 | 168,126 (Direct) |
View |
2023-09-20 Sale |
2023-09-21 5:06 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
742 | $1.245 | $924 | 68,318 (Direct) |
View |
2023-08-18 Sale |
2023-08-21 4:32 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
243 | $1.414 | $344 | 69,060 (Direct) |
View |
2023-07-19 Sale |
2023-07-20 4:38 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
106 | $1.585 | $168 | 69,303 (Direct) |
View |
2023-06-21 Sale |
2023-06-22 4:45 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
603 | $1.483 | $894 | 69,409 (Direct) |
View |
2023-05-17 Sale |
2023-05-18 4:07 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
219 | $1.624 | $356 | 70,012 (Direct) |
View |
2023-04-19 Sale |
2023-04-20 4:12 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
115 | $1.278 | $147 | 70,231 (Direct) |
View |
2023-03-17 Sale |
2023-03-20 4:16 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
526 | $1.7823 | $937 | 70,346 (Direct) |
View |
2023-03-07 Sale |
2023-03-08 4:22 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
5,090 | $5.055 | $25,730 | 48,572 (Direct) |
View |
2022-10-18 Sale |
2022-10-19 4:11 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
107 | $7.69 | $823 | 53,662 (Direct) |
View |
2022-09-19 Sale |
2022-09-20 4:09 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
255 | $6.921 | $1,765 | 53,769 (Direct) |
View |
2022-08-31 Purchase |
2022-08-31 4:14 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
1,000 | $7.46 | $7,460 | 54,024 (Direct) |
View |
2022-08-17 Sale |
2022-08-18 4:10 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
199 | $6.815 | $1,356 | 53,024 (Direct) |
View |
2022-07-19 Sale |
2022-07-20 4:27 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
431 | $6.582 | $2,837 | 53,223 (Direct) |
View |
2022-06-17 Sale |
2022-06-21 4:06 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
256 | $4.9 | $1,254 | 53,654 (Direct) |
View |
2022-05-17 Sale |
2022-05-18 4:30 pm |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
196 | $5.981 | $1,172 | 53,910 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-03-14 Option Award |
2025-03-17 5:16 pm |
N/A 2035-03-14 |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
404,000 | $0 | 563,759 (Direct) |
View |
2024-03-14 Option Award |
2024-03-15 4:35 pm |
N/A 2034-03-14 |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
250,000 | $0 | 318,318 (Direct) |
View |
2023-03-14 Option Award |
2023-03-15 09:22 am |
N/A 2033-03-14 |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
116,800 | $0 | 165,372 (Direct) |
View |
2022-06-07 Option Award |
2022-06-09 4:46 pm |
N/A 2032-06-07 |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
52,000 | $0 | 52,000 (Direct) |
View |
2022-03-14 Option Award |
2022-03-16 5:11 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
13,000 | $0 | 111,106 (Direct) |
View |
Ownership |
2022-03-09 4:53 pm |
N/A N/A |
Esperion Therapeutics Inc. | ESPR | Warren Eric Chief Commercial Officer |
0 | $0 | 41,106 (Direct) |
View |